RET/PTC-positive samples were associated (not statistically significant) with a higher rate of tumor growth (mostly T3/T4 classification), more frequent extrathyroidal extension, intravascular invasion and multifocality compared to BRAF-positive samples. This evidence concerns the gene BRAF and neoplasm.